Novavax Inc (NVAX)
8.05
-0.01
(-0.12%)
USD |
NASDAQ |
Nov 21, 16:00
7.95
-0.10
(-1.24%)
After-Hours: 20:00
Novavax Shares Outstanding: 160.18M for Oct. 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 31, 2024 | 160.18M |
September 30, 2024 | 160.15M |
July 31, 2024 | 160.09M |
June 30, 2024 | 159.89M |
May 10, 2024 | 147.30M |
May 08, 2024 | 140.42M |
April 30, 2024 | 140.40M |
April 22, 2024 | 140.40M |
March 31, 2024 | 140.37M |
February 29, 2024 | 139.95M |
February 23, 2024 | 139.95M |
December 31, 2023 | 139.51M |
October 31, 2023 | 118.79M |
September 30, 2023 | 118.73M |
August 08, 2023 | 100.90M |
July 31, 2023 | 94.40M |
June 30, 2023 | 94.31M |
April 30, 2023 | 86.31M |
April 18, 2023 | 86.30M |
March 31, 2023 | 86.29M |
February 21, 2023 | 86.17M |
December 31, 2022 | 86.04M |
December 20, 2022 | 85.98M |
October 31, 2022 | 78.50M |
September 30, 2022 | 78.48M |
Date | Value |
---|---|
July 31, 2022 | 78.22M |
June 30, 2022 | 78.17M |
April 30, 2022 | 78.13M |
April 19, 2022 | 78.13M |
March 31, 2022 | 78.12M |
February 21, 2022 | 76.28M |
December 31, 2021 | 75.84M |
October 31, 2021 | 75.61M |
September 30, 2021 | 75.42M |
July 31, 2021 | 74.48M |
June 30, 2021 | 74.25M |
April 30, 2021 | 74.09M |
April 27, 2021 | 74.09M |
April 20, 2021 | 74.08M |
April 19, 2021 | 74.08M |
March 31, 2021 | 74.06M |
February 24, 2021 | 73.86M |
January 20, 2021 | 71.85M |
December 31, 2020 | 70.95M |
October 31, 2020 | 63.66M |
September 30, 2020 | 62.93M |
July 31, 2020 | 61.28M |
June 30, 2020 | 61.21M |
June 16, 2020 | 58.69M |
May 12, 2020 | 58.65M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
32.12M
Minimum
Dec 26 2019
160.18M
Maximum
Oct 31 2024
88.83M
Average
78.13M
Median
Shares Outstanding Benchmarks
Pfizer Inc | 5.667B |
Moderna Inc | 384.82M |
Inovio Pharmaceuticals Inc | 26.10M |
Baxter International Inc | 510.59M |
Halozyme Therapeutics Inc | 127.23M |